Summary for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions

for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions Chakravarthy B. Reddy, Malcolm M. DeCamp, Rebecca L. Diekemper, Michael K. Gould, Travis Henry, Narayan P. Iyer, Y. C. Gary Lee, Sandra Z. Lewis, Nick A. Maskell, Najib M. Rahman, Daniel H. Sterman, Momen M. Wahidi, Alex A. Balekian, and David J. Feller-Kopman Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah; Division of Thoracic Surgery, Northwestern Memorial Hospital, Chicago, Illinois; Doctor Evidence LLC, Santa Monica, California; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, California; Children’s Hospital Los Angeles, Los Angeles, California; Department of Medicine and Lung Institute of Western Australia, University of Western Australia, Perth, Western Australia, Australia; Academic Respiratory Unit, University of Bristol, Bristol, United Kingdom; Oxford Respiratory Trials Unity, University of Oxford, Oxford, United Kingdom; Department of Pulmonary, Critical Care, and Sleep Medicine, NYU Langone Medicine Center, New York, New York; Department of Pulmonary and Critical Care Medicine, Duke University School ofMedicine, Durham,North Carolina; Division of Pulmonary andCritical CareMedicine, University of Southern California, Los Angeles, California; and Pulmonary and Critical Care Division, The Johns Hopkins University School of Medicine, Baltimore, Maryland

[1]  T. Henry,et al.  Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.

[2]  Y. C. Lee,et al.  Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial , 2017, JAMA.

[3]  J. Burgers,et al.  A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). , 2017, Lung cancer.

[4]  A. Tremblay,et al.  US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample , 2017, Chest.

[5]  H. Jones,et al.  Interventions for the management of malignant pleural effusions: a network meta-analysis. , 2016, The Cochrane database of systematic reviews.

[6]  J. M. Porcel,et al.  Clinical features and survival of lung cancer patients with pleural effusions , 2015, Respirology.

[7]  Elisa Anselmi,et al.  Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer , 2014, World Journal of Surgical Oncology.

[8]  S. Lanes,et al.  Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. , 2013, Chest.

[9]  Y. C. Lee,et al.  Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. , 2012, Chest.

[10]  R. Davies,et al.  Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. , 2012, JAMA.

[11]  M. Raza Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2011 .

[12]  Edmund Neville,et al.  Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.

[13]  D. Feller-Kopman,et al.  Pneumothorax following thoracentesis: a systematic review and meta-analysis. , 2010, Archives of internal medicine.

[14]  G. Michaud,et al.  Natural History of Asymptomatic Pleural Effusions in Lung Cancer Patients , 2007 .

[15]  E. Scalzetti,et al.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. , 2005, Chest.

[16]  J. Roth,et al.  Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. , 2000, The Annals of thoracic surgery.

[17]  K. Kovitz,et al.  A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions , 1999, Cancer.

[18]  M. Chuang,et al.  Elastance of the Pleural Space: A Predictor for the Outcome of Pleurodesis in Patients with Malignant Pleural Effusion , 1997, Annals of Internal Medicine.